Physicians’ Education Resource® to Host 15th Annual International Symposium on Melanoma and Other Cutaneous Malignancies®

“We are looking forward to hosting our International Symposium on Melanoma and Other Cutaneous Malignancies^® once again in New York City,” said Phil Talamo, president of PER.^® “Now in its 15th year, the symposium continues to provide physicians with the tools they need to personalize care for every patient they treat with skin and other cutaneous including some very exciting data in the adjuvant setting.”

Throughout the international conference, world-renowned melanoma experts Hamid and Weber, along with distinguished skin cancer specialists, will host several sessions covering topics such as current advances in immunotherapy and targeted therapies, the benefits of regional therapy, how to use predictive and prognostic modeling and how to manage treatment-related adverse events associated with emerging strategies. This symposium will also feature a Medical Crossfire^®, in which the expert panel will address attendees’ questions and participate in a rigorous debate on pressing issues faced by the skin cancer treatment community.

This highly interactive symposium will also feature a special presentation, “We Are What We Eat: How the Microbiome Influences Responses to Immunotherapy in Cancer,” by Thomas F. Gajewski, M.D., Ph.D., AbbVie Foundation professor of cancer immunotherapy at University of Chicago Medicine. Gajewski investigates and develops new treatments for patients with melanoma. He also serves as an editor for Cancer Research and the Journal for Immunotherapy of Cancer.

The 15th annual International Symposium on Melanoma and Other Cutaneous Malignancies^® is a one-day conference, revolutionizing the presentation of emerging therapies and evolving standards of care in the management of patients with melanoma and other skin cancers. Attendees who attend this educational conference will gain insight on the latest strategies for the use of checkpoint inhibitors, current and emerging treatments for the BRAF gene as it affects mutant melanoma, and mitigating treatment-related toxicities with targeted therapy and immunotherapies.

For more information and to register, click here.

About Physicians’ Education Resource^® (PER^®)

Since 1995, PER^® has been dedicated to advancing cancer care through professional education and now furthers patient care and treatment strategies on a wide variety of chronic illnesses and diseases. In 2016, PER^® initiated CME programming in the cardiovascular and endocrinology areas. While continuing to expand into topics outside of oncology, PER^® remains the leading provider of live, online and print CME activities related to oncology and hematology. The high-quality, evidence-based activities feature leading distinguished experts who focus on the application of practice-changing advances. PER^® is accredited by the Accreditation Council for Continuing Medical Education and the California Board of Registered Nursing. PER^® is part of the Cranbury, New Jersey-based MJH Associates Inc. family of businesses. Learn more at http://www.gotoper.com and http://www.mjhassoc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190117005531/en/